Literature DB >> 11529924

Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization.

R Giacomelli1, P Cipriani, A Fulminis, G Barattelli, M Matucci-Cerinic, S D'Alò, G Cifone, G Tonietti.   

Abstract

Systemic sclerosis (SSc) is a connective tissue disease in which immune system activation is evidenced by high levels of different cytokines in the sera and/or in the supernatants of cultured peripheral blood mononuclear cells (PBMC) and by the presence of specific autoantibodies. gamma/delta T cells accumulate in the lung and the skin of SSc patients suggesting their potential role in the development and maintenance of the disease. The aim of this study was to assess cytokine production and cytotoxic activity of circulating gamma/delta T lymphocytes obtained from SSc patients and to evaluate their potential role during this disorder. Our results showed that both the proportion and the absolute number of IFN-gamma gamma/delta-producing cells (i.e. displaying a Th1 polarization) in SSc was significantly higher than either the proportion and the absolute number of IL-4 gamma/delta-producing cells in SSc or the proportion and the absolute number of IFN-gamma gamma/delta-producing cells in healthy controls (P < 0.05 for both groups). Furthermore, the cytotoxic activity of enriched gamma/delta T cells was significantly increased in SSc patients compared with controls. The results concerning the Vdelta1+ T cell subset paralleled those of total gamma/delta T lymphocytes. In contrast, alpha/beta T cells from SSc and control subjects displayed Th2 cytokine production. All these findings were independent of both disease subset and clinical status. Our data demonstrate that, although SSc is generally considered a Th2 autoimmune disease, Th1 polarization of gamma/delta T cells and an increase in their cytotoxic activity is observed in SSc, suggesting that gamma/delta T cells could have a relatively autonomous role in the pathogenesis in this disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529924      PMCID: PMC1906121          DOI: 10.1046/j.1365-2249.2001.01603.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  Gammadelta receptor bearing T cells in scleroderma: enhanced interaction with vascular endothelial cells in vitro.

Authors:  M B Kahaleh; P S Fan; T Otsuka
Journal:  Clin Immunol       Date:  1999-05       Impact factor: 3.969

Review 2.  Th1 and Th2 cells in autoimmunity.

Authors:  P Druet; R Sheela; L Pelletier
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

3.  IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: relationship between vimentin and CD23.

Authors:  N J Klein; K P Rigley; R E Callard
Journal:  Int Immunol       Date:  1993-03       Impact factor: 4.823

Review 4.  Raynaud's phenomenon and the vascular disease in scleroderma.

Authors:  M B Kahaleh
Journal:  Curr Opin Rheumatol       Date:  1995-11       Impact factor: 5.006

5.  Different cytokine production profiles of gamma delta T cell clones: relation to inflammatory arthritis.

Authors:  P Chomarat; J Kjeldsen-Kragh; A J Quayle; J B Natvig; P Miossec
Journal:  Eur J Immunol       Date:  1994-09       Impact factor: 5.532

6.  Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma delta + T-cell receptor.

Authors:  S A Huber; A Mortensen; G Moulton
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

7.  CDR3-independent gamma delta V delta 1+ T cell expansion in the peripheral blood of HIV-infected persons.

Authors:  S Boullier; M Cochet; F Poccia; M L Gougeon
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

8.  Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.

Authors:  V Rus; A Svetic; P Nguyen; W C Gause; C S Via
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

9.  Natural killer cells and gamma delta T cells in scleroderma: relationship to disease duration and anti-Scl-70 antibodies.

Authors:  R F Holcombe; B A Baethge; R E Wolf; K W Betzing; R M Stewart
Journal:  Ann Rheum Dis       Date:  1995-01       Impact factor: 19.103

Review 10.  Immunologic aspects of scleroderma.

Authors:  B White
Journal:  Curr Opin Rheumatol       Date:  1994-11       Impact factor: 5.006

View more
  9 in total

Review 1.  The pathogenesis of systemic sclerosis revisited.

Authors:  Matthias Geyer; Ulf Müller-Ladner
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

2.  Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model.

Authors:  Ayumi Yoshizaki; Koichi Yanaba; Yohei Iwata; Kazuhiro Komura; Asako Ogawa; Yuichiro Akiyama; Eiji Muroi; Toshihide Hara; Fumihide Ogawa; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Thomas F Tedder; Shinichi Sato
Journal:  J Immunol       Date:  2010-07-12       Impact factor: 5.422

3.  Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis.

Authors:  H Fujii; M Hasegawa; K Takehara; N Mukaida; S Sato
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

4.  Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.

Authors:  E Scala; S Pallotta; A Frezzolini; D Abeni; C Barbieri; F Sampogna; O De Pità; P Puddu; R Paganelli; G Russo
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

5.  Apoptosis modulation as a promising target for treatment of systemic sclerosis.

Authors:  Stéphane Chabaud; Véronique J Moulin
Journal:  Int J Rheumatol       Date:  2011-09-06

6.  Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2.

Authors:  Donatella Amico; Tatiana Spadoni; Marina Rovinelli; Marta Serafini; Giovanna D'Amico; Nadia Campelli; Silvia Svegliati Baroni; Armando Gabrielli
Journal:  Arthritis Res Ther       Date:  2015-03-17       Impact factor: 5.156

7.  Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.

Authors:  Pravitt Gourh; Frank C Arnett; Shervin Assassi; Filemon K Tan; Mei Huang; Laura Diekman; Maureen D Mayes; John D Reveille; Sandeep K Agarwal
Journal:  Arthritis Res Ther       Date:  2009-10-02       Impact factor: 5.156

8.  Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.

Authors:  Paola Di Benedetto; Giuliana Guggino; Giovanna Manzi; Piero Ruscitti; Onorina Berardicurti; Noemi Panzera; Nicolò Grazia; Roberto Badagliacca; Valeria Riccieri; Carmine Dario Vizza; Ganna Radchenko; Vasiliki Liakouli; Francesco Ciccia; Paola Cipriani; Roberto Giacomelli
Journal:  Arthritis Res Ther       Date:  2020-06-01       Impact factor: 5.156

Review 9.  Perforins Expression by Cutaneous Gamma Delta T Cells.

Authors:  Katelyn O'Neill; Irena Pastar; Marjana Tomic-Canic; Natasa Strbo
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.